NCT00742144 2017-11-17Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic LeukemiaGlaxoSmithKlinePhase 1 Completed6 enrolled
NCT01119794 2015-08-26Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After RituximabBrown UniversityPhase 2 Terminated10 enrolled 7 charts